Medicare Enrolled
Dr. Ha Tran, M.D.
Hematology & Oncology · Stockbridge, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tran
Dr. Ha Tran is a hematology & oncology specialist in Stockbridge, GA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Tran performed 6,880 Medicare services across 876 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tran received a total of $2,647 from 47 pharmaceutical and/or device companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 20% volume in GA
$2,647 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,880
Medicare services
Top 20% in GA for hematology & oncology
876
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~382 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,540 | $17 | $44 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
966 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
547 | $8 | $27 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
252 | $63 | $168 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
196 | $22 | $118 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $91 | $260 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
183 | $11 | $60 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
172 | $100 | $525 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
145 | $12 | $82 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
98 | $49 | $235 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
85 | $49 | $250 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
77 | $22 | $131 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
72 | $16 | $90 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
60 | $1 | $2 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
44 | $1 | $3 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
39 | $2 | $5 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
37 | $10 | $97 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
37 | $136 | $376 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $24 | $194 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $112 | $429 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
22 | $3 | $15 |
| New patient office visit, complex (60-74 min) | 20 | $149 | $544 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $56 | $172 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $31 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.1% high complexity
72.3% medium
17.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,647
Total received (2018-2024)
Avg $378/year across 7 years
Bottom 44% in GA for hematology & oncology
47
Companies
134
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,469 (93.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$178 (6.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$654
2023
$756
2022
$462
2021
$210
2020
$174
2019
$167
2018
$223
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$85
Ipsen Biopharmaceuticals, Inc
$64
Celgene Corporation
$52
Daiichi Sankyo Inc.
$47
Regeneron Healthcare Solutions, Inc.
$42
PFIZER INC.
$34
Novartis Pharmaceuticals Corporation
$31
Astellas Pharma US Inc
$27
Janssen Biotech, Inc.
$26
Merck Sharp & Dohme LLC
$25
SOBI, INC
$24
BeiGene USA, Inc.
$22
Rigel Pharmaceuticals, Inc.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
TerSera Therapeutics LLC
$21
SpringWorks Therapeutics, Inc.
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Alexion Pharmaceuticals, Inc.
$19
Deciphera Pharmaceuticals Inc.
$18
Kyowa Kirin, Inc.
$18
ARRAY BIOPHARMA INC
$15
Top 3 companies account for 30.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$252
Merck Sharp & Dohme LLC
$220
PFIZER INC.
$219
Janssen Biotech, Inc.
$176
Merck Sharp & Dohme Corporation
$133
Daiichi Sankyo Inc.
$113
Genentech USA, Inc.
$100
Rigel Pharmaceuticals, Inc.
$92
Ipsen Biopharmaceuticals, Inc
$89
ABBVIE INC.
$85
BeiGene USA, Inc.
$66
GENZYME CORPORATION
$66
Pharmacyclics LLC, an AbbVie Company
$65
AbbVie Inc.
$64
Regeneron Healthcare Solutions, Inc.
$62
TerSera Therapeutics LLC
$61
Astellas Pharma US Inc
$56
E.R. Squibb & Sons, L.L.C.
$54
Celgene Corporation
$52
Amgen Inc.
$42
Pharmacyclics LLC, An AbbVie Company
$40
Gilead Sciences, Inc.
$34
Kite Pharma, Inc.
$31
ARRAY BIOPHARMA INC
$31
McKesson Specialty Care Distribution, LLC
$29
SOBI, INC
$24
Eisai Inc.
$24
Stemline Therapeutics Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$22
Takeda Pharmaceuticals U.S.A., Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
Seagen Inc.
$21
G1 Therapeutics, Inc.
$20
SpringWorks Therapeutics, Inc.
$20
Puma Biotechnology, Inc.
$20
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Alexion Pharmaceuticals, Inc.
$19
Deciphera Pharmaceuticals Inc.
$18
Helsinn Therapeutics (U.S.), Inc.
$18
Kyowa Kirin, Inc.
$18
ADC Therapeutics America, Inc.
$17
Lilly USA, LLC
$17
SERVIER PHARMACEUTICALS LLC
$17
AstraZeneca Pharmaceuticals LP
$15
Janssen Pharmaceuticals, Inc
$13
Karyopharm Therapeutics Inc.
$12
EMD Serono, Inc.
$11
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
AKYNZEO · Alecensa · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · COSELA · DARZALEX · ELIQUIS · ELITEK · EPKINLY · ERBITUX · Enhertu · Erivedge · FRUZAQLA · IBRANCE · IMBRUVICA · INJECTAFER · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LORBRENA · LUPRON DEPOT · Lenvima · MEKINIST · OGSIVEO · OPDIVO · OXBRYTA · Onivyde · Orserdu · PIQRAY · PLUVICTO · Padcev · Perjeta · Poteligeo · QINLOCK · REBLOZYL · Rezlidhia · SARCLISA · SYLVANT · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · Tibsovo · ULTOMIRIS · VENCLEXTA · VONJO · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · YONSA · Yescarta · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
147
Per 100K population
59.9
County median income
$81,612
Nearest hospital
PIEDMONT HENRY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tran is a mixed practice specialist, with above-average Medicare volume (top 20% in GA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tran experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Tran performed 3,540 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tran receive payments from pharmaceutical companies?
Yes. Dr. Tran received a total of $2,647 from 47 companies across 134 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tran's costs compare to other hematology & oncology specialists in Stockbridge?
Dr. Tran's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Stockbridge
Browse hematology & oncology specialists in Stockbridge ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in GA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in GA
Which GA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology